February 2020

Employers Support Bipartisan Bill to Increase Drug Price Transparency and Reduce Gaming by Middlemen

2020-02-24T13:56:49-05:00February 24th, 2020|EmployersRx, Policy Statement|

EmployersRx endorses H.R. 5304 as part of ongoing initiative to lower drug prices through increased competition, value, and transparency in the market WASHINGTON, D.C. – Employers’ Prescription for Affordable Drugs (EmployersRx) has announced its support of H.R. 5304, the "PBM Transparency and Prescription Drug Costs Act." This bipartisan legislation will markedly lower private health insurance

December 2019

Employers Applaud Advancement of the CREATES Act and Transparency Measures, View 2020 as a Transformational Year in Drug Pricing

2019-12-19T18:04:54-05:00December 19th, 2019|EmployersRx, Policy Statement|

Elements of Policy Platform—the CREATES Act and “Purple Book” Transparency—Advance Through Congress; Large Issues Remain on Table for 2020 WASHINGTON, D.C. – Employers’ Prescription for Affordable Drugs (EmployersRx) applauded Congress for including the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act and portions of the Biologic Patent Transparency Act in an omnibus government

November 2019

Employers: House and Senate Proposals Move Us Closer to Prescription Drug Cost Relief for Patients and Employers

2019-11-05T12:31:00-05:00November 5th, 2019|EmployersRx, Policy Statement|

WASHINGTON, D.C. – Employers’ Prescription for Affordable Drugs (EmployersRx) issued this statement in conjunction with the ongoing debate of the Lower Drug Costs Now Act of 2019 (H.R. 3), the Prescription Drug Pricing Reduction Act (S. 2543), the Lower Health Care Costs Act (S. 1895), and other legislation proposed by both parties in the U.S.